The Patent Finder

Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban

Vanderbilt University

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 62/118,896, filed Feb 20, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,693,998Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
In force
 · High confidence
Cumberland Pharmaceuticals, Inc. and Vanderbilt UniversityIn force
High confidence
US 10,016,399Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
In force
 · High confidence
Cumberland Pharmaceuticals Inc. and Vanderbilt UniversityIn force
High confidence
US 10,314,824Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
In force
 · High confidence
Cumberland Pharmaceuticals Inc. and Vanderbilt UniversityIn force
High confidence
US 10,583,126Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
In force
 · High confidence
Cumberland Pharmaceuticals Inc. and Vanderbilt UniversityIn force
High confidence
US 10,925,860Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
In force
 · High confidence
Cumberland Pharmaceuticals Inc. and Vanderbilt UniversityIn force
High confidence
US 12,161,632Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
In force
 · Medium confidence
Cumberland Pharmaceuticals Inc. and Vanderbilt UniversityIn force
Medium confidence
Application 17/151,181Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
Abandoned
Abandoned Jul 12, 2023
Cumberland Pharmaceuticals Inc. and Vanderbilt UniversityAbandonedAbandoned Jul 12, 2023
Application 18/927,657Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
Pending
Not granted
Cumberland Pharmaceuticals Inc. and Vanderbilt UniversityPendingNot granted
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Vanderbilt University.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited